COMMUNIQUÉS West-GlobeNewswire

-
Pédalons pour la cause : la Jack Ride mobilise le pays pour la santé mentale des jeunes
12/02/2025 - 15:00 -
Pedal for Progress with Jack Ride: Canadians Ride for Youth Mental Health
12/02/2025 - 15:00 -
Board member Roland Norberg requests to resign from the Board
12/02/2025 - 16:00 -
Orchestra BioMed Announces Data Demonstrating Favorable Impact of AVIM Therapy on Diastolic Dysfunction, a Key Driver of Heart Failure Progression, will be Presented as Late-Breaking Science at the THT 2025 Conference
12/02/2025 - 16:43 -
Tanke Biosciences Corp Announces Appointment of Vincent Renz as Chief Executive Officer and Member of the Board of Directors
12/02/2025 - 17:00 -
Genmab Publishes 2024 Annual Report
12/02/2025 - 17:01 -
Invitation to the presentation of ALK’s annual report 2024 on Wednesday, 19 February 2025
12/02/2025 - 17:02 -
Legend Senior Living® Expands with New Residence in King of Prussia
12/02/2025 - 17:19 -
FDA approves Roche’s Evrysdi tablet as first and only tablet for Spinal Muscular Atrophy (SMA)
12/02/2025 - 17:45 -
EssilorLuxottica: Résultats T4 et annuels 2024 - Solide croissance du chiffre d’affaires et augmentation de la marge en 2024. Un nouveau vecteur de croissance : les lunettes connectées, débuts prometteurs de Nuance Audio
12/02/2025 - 18:00 -
EssilorLuxottica: Q4/FY 2024 Results - Sound sales growth and margin expansion in 2024. Smartglasses as a new driver, Nuance off to a promising start
12/02/2025 - 18:00 -
SAFE GROUP - CHIFFRE D’AFFAIRES 2024
12/02/2025 - 18:34 -
MiNK Therapeutics to Present Updated Data from Phase 2 Study Testing AgenT-797 in Gastric Cancer at AACR IO Annual Meeting
12/02/2025 - 19:00 -
Genmab Files Annual Report with the U.S. Securities and Exchange Commission
12/02/2025 - 19:14 -
Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)
12/02/2025 - 20:00 -
CVRx announces new real-world evidence demonstrating significant reductions in healthcare utilization with Barostim
12/02/2025 - 20:45 -
Mdxhealth to Present Fourth Quarter and Full Year 2024 Financial Results and Corporate Update on February 26
12/02/2025 - 22:00 -
atai Life Sciences Announces Proposed Public Offering of Common Shares
12/02/2025 - 22:01 -
Ascendis Pharma Reports Fourth Quarter and Full Year 2024 Financial Results
12/02/2025 - 22:01
Pages